Skip to content
MedNess logo
MedNess Stempeers
Facebook Linkedin Twitter
Facebook Linkedin Twitter

Inside the
Mind

ADC SPOTLIGHT

Diagnostic
Digest

Flow
Focus

Neuro
Horizons

Care For
Rare

FDA
Feeds

Digital
Health

Archive

About
us

  • Inside The Mind
  • ADC Spotlight
  • Diagnostic Digest
  • Flow Focus
  • Neuro Horizons
  • Care For Rare
  • FDA Feeds
  • Digital Health
  • Archive
  • About Us
  • Inside The Mind
  • ADC Spotlight
  • Diagnostic Digest
  • Flow Focus
  • Neuro Horizons
  • Care For Rare
  • FDA Feeds
  • Digital Health
  • Archive
  • About Us

Brentuximab Vedotin Combination Approved for Relapsed/Refractory Large B-Cell Lymphoma

February 19, 2025

Semaglutide: A Breakthrough in Obesity Treatment

January 29, 2025

Semaglutide Enhances Glycemic Control with Automated Insulin Delivery in Type 1 Diabetes

January 16, 2025

Expanding Global Access to Mpox Vaccines: A Strategic Partnership Between Bavarian Nordic and Serum Institute of India

January 9, 2025

FDA Approves Obecabtagene Autoleucel for Advanced B-Cell Acute Lymphoblastic Leukemia

November 20, 2024

FDA Approves Zolbetuximab-clzb for Advanced Gastric and GEJ Adenocarcinoma

October 30, 2024

FDA Approval of Inavolisib Combination Therapy for PIK3CA-Mutated, HR-Positive, HER2-Negative Breast Cancer

October 23, 2024

Nivolumab Approved for Neoadjuvant and Adjuvant Therapy in Resectable NSCLC: A New Horizon for Lung Cancer Treatment

October 9, 2024

Wegovy®: Expanding Benefits for Obesity-Related Heart Failure with Preserved Ejection Fraction

October 2, 2024

Nanotechnology: Revolutionizing Diabetes Treatment and Diagnostics

September 25, 2024

Once-Weekly Insulins Show Promise in Simplifying Diabetes Management

September 18, 2024

Precision in NSCLC Treatment: The Predictive Power of TROP2-QCS in Datopotamab Deruxtecan Therapy

September 11, 2024

FDA Approves Lazertinib and Amivantamab-vmjw Combination for First-Line Treatment of EGFR-Mutant NSCLC

August 29, 2024

FDA Approves Neoadjuvant/Adjuvant Durvalumab for Resectable NSCLC

August 23, 2024

FDA Grants Accelerated Approval to Afamitresgene Autoleucel for Unresectable or Metastatic Synovial Sarcoma

August 14, 2024

FDA Expands Endometrial Cancer Indication for Dostarlimab-gxly with Chemotherapy

August 8, 2024

FDA Approves Daratumumab and Hyaluronidase-fihj Combination for Multiple Myeloma

August 1, 2024

Merck Signs MoU with Gene Therapy Research Institution to Advance Gene Therapy Production

July 25, 2024

FDA Grants Accelerated Approval to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma

July 11, 2024

FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-Mutated Colorectal Cancer

July 4, 2024

FDA Approves Blinatumomab as Consolidation Therapy for CD19-Positive Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia

June 25, 2024

FDA Grants Accelerated Approval to Repotrectinib for NTRK Fusion-Positive Tumors

June 19, 2024

US FDA Approves Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma

June 12, 2024

Follicular Lymphoma Treatment Option Gains FDA Approval: Lisocabtagene Maraleucel

May 31, 2024

FDA Grants Accelerated Approval to Tarlatamab-dlle for ES-SCLC

May 22, 2024

Sanofi & Novavax Partner on COVID-19 and Flu Combination Vaccines

May 15, 2024

Accelerated Approval of Tovorafenib for Pediatric Low-Grade Glioma: A Breakthrough in BRAF-Altered Therapy

May 8, 2024

The US FDA approves lutetium Lu 177 dotatate for pediatric patients with GEP-NETS

May 1, 2024

FDA Approval of Nogapendekin Alfa inbakicept-pmln: A Breakthrough in Bladder Cancer Treatment

April 25, 2024

Advancing Alzheimer’s Disease Diagnosis

April 17, 2024
Page1 Page2

Stay up-to-date with our biotech news

Check your inbox or spam folder to confirm your subscription.

Facebook Linkedin Twitter
  • Inside The Mind
  • ADC Spotlight
  • Diagnostic Digest
  • Flow Focus
  • Neuro Horizons
  • Care For Rare
  • FDA Feeds
  • Digital Health
  • Vaccine Watch
  • Guest Column
  • Archive

About Us

Disclaimer: The editors take care to share authentic information. In case of any discrepancies please write to newsletter @ medness.org
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer to peer mentoring and support.

Facebook Linkedin Twitter
  • ADCs in focus
  • Care For Rare
  • Diagnostic Digest
  • Disease Disruptors
  • Metabolic Disorders
  • Neuro Horizons
  • Vaccine Watch
  • Guest Column

About Us

Disclaimer: The editors take care to share authentic information. In case of any discrepancies please write to newsletter @ medness.org
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer to peer mentoring and support.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT